2016. Bioethics of intervention and the case of drugs Bevacizumab and Ranibizumab for retinal diseases. Revista Iberoamericana de Bioética. 2 (Oct. 2016), 1–10. DOI:https://doi.org/10.14422/rib.i02.y2016.004.